27Serious

Peter Williams

Peter Williams

Ask VT AI

View News Summary

Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.
Hershey slashes prices as retailers offer steep discounts on seasonal candy amid rising costs and soft Halloween sales.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.
Hershey slashes prices as retailers offer steep discounts on seasonal candy amid rising costs and soft Halloween sales.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Peter Williams